Literature DB >> 7428677

Characterization of progesterone receptors, estrogen receptors, and estrogen (type II)-binding sites in the hormone-independent variant of the MXT-3590 mouse mammary tumor.

C S Watson, D Medina, J H Clark.   

Abstract

A hormone-independent mouse mammary tumor line was derived by transplantation of a hormone-dependent line (MXT-3590) into ovariectomized-adrenalectomized animals and subsequent transplantation of surviving tumors. Although the tumor line is hormone independent, it contains a full complement of estrogen and progesterone receptors which are similar to those found in hormone-dependent tumors. This similarity includes the criteria of nuclear translocation of the estrogen receptor and subsequent stimulation of progesterone receptor synthesis. In addition to the estrogen receptor, a secondary estrogen-binding site (type II) is also present; this binding site was previously described in the hormone-dependent companion tumor line. Thus, while this variant tumor line contains the biosynthetic pathways that control estrogen and progesterone receptor synthesis, its growth does not depend on these steroids. Therefore, it may provide a good model for the study of this class of hormone-independent tumors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428677     DOI: 10.1210/endo-107-5-1432

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Long-term effects of estrogen on avian liver: estrogen-inducible switch in expression of nuclear, hormone-binding proteins.

Authors:  R J Haché; S P Tam; A Cochrane; M Nesheim; R G Deeley
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

2.  Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells.

Authors:  Barry M Markaverich; Mary Vijjeswarapu; Kevin Shoulars; Mary Rodriguez
Journal:  J Steroid Biochem Mol Biol       Date:  2010-06-15       Impact factor: 4.292

3.  Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status.

Authors:  Jisen Dai; Jinlong Jian; Maarten Bosland; Krystyna Frenkel; Güenther Bernhardt; Xi Huang
Journal:  Breast       Date:  2007-10-24       Impact factor: 4.380

4.  Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes.

Authors:  T Spruss; G Bernhardt; E Schickaneder; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Antitumour activity of miltefosine alone and after combination with platinum complexes on MXT mouse mammary carcinoma models.

Authors:  T Spruss; G Bernhardt; H Schönenberger; J Engel
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Multiple Sites of Type II Site Ligand (Luteolin and BMHPC) Regulation of Gene Expression in PC-3 Cells.

Authors:  Barry M Markaverich; Mary Vijjeswarapu
Journal:  Int J Biomed Sci       Date:  2012-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.